Absence of host B7 expression is sufficient for long-term murine vascularized heart allograft survival

Transplantation

Volumn 69, Issue 5, 2000, Pages 904-909

  Szot, Gregory L ^a   Zhou, Ping ^a   Sharpe, Arlene H ^b   He, Gang ^a   Kim, Oliver ^a   Newell, Kenneth A ^a   Bluestone, Jeffrey A ^a   Thistlethwaite Jr , J Richard ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b HARVARD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD28 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; HLA B7 ANTIGEN; RECOMBINANT INTERLEUKIN 2;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; GRAFT REJECTION; GRAFT SURVIVAL; HEART TRANSPLANTATION; IMMUNOLOGICAL TOLERANCE; IMMUNOSTIMULATION; KNOCKOUT MOUSE; MOUSE; NONHUMAN; PRIORITY JOURNAL; STRAIN DIFFERENCE; TREATMENT OUTCOME;

EID: 0034653663     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200003150-00040     Document Type: Article

References (24)

1. Bluestone JA. Costimulation and its role in organ transplantation. Clin Transplant 1996; 1: 104.
2. Lenschow DJ, Walunas TL, Bluestone JA. CD28/B7 system of T cell costimulation. Annu Rev Immunol 1996; 14: 233.
3. Akalin E, Chandraker A, Russell ME, Turka LA, Hancock WW, Sayegh MH. CD28-B7 T cell costimulatory blockade by CTLA4Ig in the rat renal allograft model; inhibition of cell-mediated and humoral immune responses in vivo. Transplantation 1996; 62: 1942.
4. Larsen CP, Elwood ET, Alexander DZ, et al. Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways. Nature 1996; 381: 434.
5. Lenschow DJ, Zeng Y, Hathcock K, et al. 1995. Inhibition of transplant rejection following treatment with anti-B7-2 and anti-B7-1 antibodies. Transplantation 1995; 60: 1171.
6. Lenschow DJ, Zeng Y, Thistlethwaite JR, et al. Long-term survival of xenogeneic pancreatic islet grafts induced by CTLA4Ig. Science 1992; 257: 789.
7. Schweitzer AN, Sharpe AH. Studies using antigen-presenting cells lacking expression of both B7-1 (CD80) and B7-2 (CD86) show distinct requirements for B7 molecules during priming versus restimulation of Th2 but not Th1 cytokine production. J Immunol 1998; 61: 2762.
8. Borriello F, Sethna MP, Boyd SD, et al. B7-1 and B7-2 have overlapping, critical roles in immunoglobulin class switching and germinal center formation. Immunity 1997; 6: 303.
9. + splenic T cells after CD28 receptor ligation. J Immunol 1995; 154: 985.
10. Shelby J, Wakely E, Corry RJ. Suppressor cell induction in donor-specific transfused mouse heart recipients. Surgery 1984; 96: 296.
11. Salomon B, Bluestone JA. 1998. LFA-1 interaction with ICAM-1 and ICAM-2 regulates Th2 cytokine production. J Immunol 1998; 161: 5138.
12. Leo O, Foo M, Sachs DH, Samelson LE, Bluestone JA. 1987. Identification of a monoclonal antibody specific for murine T3. Proc Natl Acad Sci USA 1987; 84: 1374.
13. Lin H, Rathmell JC, Gray GS, et al. Cytotoxic T lymphocyte antigen 4 (CTLA4) blockade accelerates the acute rejection of cardiac allografts in CD28-deficient mice: CTLA4 can function independently of CD28. J Exp Med 1998; 188: 199.
14. Walunas TL, Lenschow DJ, Bakker CY, et al. CTLA-4 can function as a negative regulator of T cell activation. Immunity 1994; 1: 405.
15. DeBenedette MA, Shahinian A, Mak TW, Watts TH. 1997. Costimulation of CD28-T lymphocytes by 4-1BB ligand. J Immunol 1997; 158: 551.
16. Zheng XX, Sayegh MH, Zheng XG, et al. The role of donor and recipient B7-1 (CD80) in allograft rejection. J Immunol 1997; 159: 1169.
17. Krieger NR, Yin DP, Fathman CG. CD4+ but not CD8+ cells are essential for allorejection. J Exp Med 1996; 184: 2013.
18. Ding L, Shavach EM. Activation of CD4+ T cells by delivering of the B7 costimulatory signal on bystander antigen-presenting cells (trans-constimulation). Eur J Immunol 1994; 24: 859.
19. Mandelbrot DA, McAdam AJ, Sharpe AH. B7-1 or B7-2 is required to produce the lymphproliferative phenotype in mice lacking cytotoxic T lymphocyte-associated antigen 4 (CTLA-4). J Exp Med 1999; 189: 435.
20. Lin H, Rathmell JC, Gray GS, Thompson CB, Leiden JM, Alegre ML. 1998. Cytotoxic T Lymphocyte antigen 4 (CTLA4) blockade accelerates the acute rejection of cardiac allografts in CD28-deficient mice: CTLA4 can function independently of CD28. J Exp Med 1998; 188: 199.
21. Zeng Y, Gage A, Montag A, Rothlein R, Thistlethwaite JR, Bluestone JA. Inhibition of transplantation by pretreatment of xenogeneic pancreatic islet cells with anti-ICAm-1 antibodies. Transplantation 1994; 58: 681.
22. LaMotte RN, Sharpe AH, Bluestone JA, Mokyr MB. Importance of B7-1-expressing host antigen presenting cells for the eradication of B7-2 transfected p815 tumor cells. J Immunol. 1998; 161: 6552.
23. + T cells and defective antibody production in vivo. J Exp Med 1994; 179: 809.
24. Judge TA, Wu Z, Zheng XG, Sharpe AH, Sayegh MH, Turka LA.The role of CD80, CD86, and CTLA4 in alloimmune responses and the inductions of long-term allograft survival. J Immunol 1999; 162: 1947.